Download Free Sample Report

Artificial Intelligence (AI) in Drug Discovery market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Artificial Intelligence (AI) in Drug Discovery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Artificial Intelligence (AI) in Drug Discovery market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

• Software
• Services

Segment by Application

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Research Centers and Academic & Government Institutes

By Region

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Asia-Pacific
• China
• Japan
• South Korea
• India
• Australia
• Taiwan
• Indonesia
• Thailand
• Malaysia
• Philippines
• Vietnam
• Latin America
• Mexico
• Brazil
• Argentina
• Middle East & Africa
• Turkey
• Saudi Arabia
• U.A.E

By Company

• IBM
• Microsoft
• Google
• NVIDIA Corporation
• Atomwise, Inc.
• Deep Genomics
• Cloud Pharmaceuticals
• Insilico Medicine
• BenevolentAI
• Exscientia
• Cyclica
• BIOAGE
• Numerate
• NuMedii
• Envisagenics
• twoXAR
• OWKIN, Inc.
• XtalPi
• Verge Genomics
• BERG LLC